Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 86 Vernadsky Prospekt, Moscow 119571, Russia.
Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24 Kashirskoe Shosse, Moscow 115478, Russia.
Molecules. 2024 Oct 11;29(20):4808. doi: 10.3390/molecules29204808.
Ribavirin and its analogues exhibit an in vitro antiproliferative effect in cancer cells. In this work, we studied the biological activities of a number of alkyl/aryloxymethyl derivatives of ribavirin's aglycon-1,2,4-triazole-3-carboxamide. Alkyl/arylxymethyl derivatives of 1,2,4-triazole-3-carboxamide with substitutions at the fifth or first position of the triazole ring, were synthesized and their antiproliferative and antimicrobial effects were assessed. For both series, the presence of an antiproliferative effect was investigated, and 1-alkyl/aryloxymethyl derivatives were shown an antimicrobial potential against a Gram-positive bacteria and Gram-negative bacterium . The obtained results showed that the n-decyloxymethyl derivatives induced leukemia cell death at low micromolar concentrations. We confirmed that n-decyloxymethyl derivatives of ribavirin inhibited the cell cycle progression and induced an accumulation of leukemia cells in the subG1-phase. The molecular docking results suggest that alkyl/aryloxymethyl derivatives may act by inhibiting translation initiation, due to interference with eIF4E assembly. The outcome results revealed that active derivatives (1- or 5-n-decyloxymethyl-1,2,4-triazole-3-carboxamides) can be considered as a lead compound for anticancer treatments.
利巴韦林及其类似物在癌细胞中表现出体外增殖抑制作用。在这项工作中,我们研究了利巴韦林的糖苷-1,2,4-三唑-3-甲酰胺的一系列烷基/芳基甲氧基衍生物的生物学活性。在三唑环的第五位或第一位具有取代基的 1,2,4-三唑-3-甲酰胺的烷基/芳基甲氧基衍生物被合成,并评估了它们的增殖抑制和抗菌作用。对于这两个系列,都研究了它们的增殖抑制作用,并且 1-烷基/芳基甲氧基衍生物显示出对革兰氏阳性菌和革兰氏阴性菌的抗菌潜力。所得到的结果表明,低微摩尔浓度的正癸基甲氧基衍生物诱导白血病细胞死亡。我们证实,利巴韦林的正癸基甲氧基衍生物通过抑制细胞周期进程并诱导白血病细胞在 subG1 期积累来抑制细胞生长。分子对接结果表明,烷基/芳基甲氧基衍生物可能通过干扰 eIF4E 组装来抑制翻译起始而发挥作用。结果表明,活性衍生物(1-或 5-正癸基-1,2,4-三唑-3-甲酰胺)可以被认为是抗癌治疗的先导化合物。